EST Timezone Workshop: Kinase Ligand Design

webinar

Thu, 29 Feb 2024, 19:00 CET (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

EST Timezone Workshop: Kinase Ligand Design

Due to widespread popularity and numerous requests for a live demonstration tailored to the American continent, we are excited to announce the re-iteration of the successful BioSolveIT workshop on kinase ligand design.

Kinases stand out as a popular focus in drug development. Their popularity is evident from the numerous FDA approvals granted to compounds targeting these specific proteins. The associated design process often integrates computational approaches such as molecular modeling and structure-based drug design, reflecting the dynamic and evolving landscape of kinase-targeted drug development.

This BioSolveIT workshop is dedicated to elucidating the basics of selective kinase inhibitor design, as well as the application of advanced techniques to optimize lead structures. Encompassing both 3D structure-based and 2D ligand-based realms, we will present and discuss several examples illustrating idea generation methods for hinge binders and the adjacent core regions. These methods will include fragment-based growing and evolution (FBDD), scaffold hopping, Chemical Space exploration involving trillions of possibilities, and various other strategies facilitated by BioSolveIT tools.

Drug discovery beginners, veterans, and medicinal chemistry enthusiasts are invited to join this highly informative workshop and the subsequent discussion.

Participants can request a certificate of attendance to confirm their completion of the event to furthering their knowledge and skills in the specified subject matter.

Current news

category
Events
Announcing BioSolveIT's DrugSpace Symposium 2025: Bridging Science
June 26, 2025 09:43 CEST
We are pleased to announce the fourth edition of the BioSolveIT DrugSpace Symposium, taking place on September 24–25, 2025. This year’s theme, “Bridging Science,” highlights the growing importance of interdisciplinary collaboration in driving innovation across the drug discovery landscape. As the field evolves, it becomes increasingly clear that real progress...
Read on
Psst... Are You Following Us Yet? Follow the Science (and a Bit More)
June 25, 2025 08:44 CEST
There’s a lot going on behind the scenes—ideas taking shape, tools evolving, science in motion. And while the website tells you what our software does, our social media gives you a look at how it lives. We’re active on LinkedIn, BlueSky, and YouTube, sharing everything from scientific snapshots to educational...
Read on
AMBrosia Just Got Bigger: 126 Billion Compound Update Now Available
June 11, 2025 13:21 CEST
We are thrilled to announce a major update to the AMBrosia Chemical Space in collaboration with Ambinter! The state-of-the-art source for diverse drug-like scaffolds now boasts an incredible 126 billion of synthetically accessible compounds for drug discovery projects. What does the update feature? Expanded to an astounding 125,924,571,692 compounds (1.26...
Read on